Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05975333 · ClinicalTrials.gov registry record · NA
Writing Intervention With Adolescents and Young Adults With Cancer
A NA study of Cancer Patients and Communication Research, sponsored by St. Jude Children's Research Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT05975333: Recruiting NA study of Cancer Patients and Communication Research, sponsored by St. Jude Children's Research Hospital.
NCT05975333 is a NA study of Cancer Patients and Communication Research that is actively recruiting participants, run by St. Jude Children's Research Hospital. The registered enrollment target is 26 participants, below the 241-participant average among 8 other Cancer Patients trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05975333, a NA study of Cancer Patients and Communication Research, is actively recruiting participants, sponsored by St. Jude Children's Research Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
Young people with cancer have difficult experiences and writing exercises may help improve their well-being. However, very few studies have examined how a creative writing activity might be useful for young people with cancer. In this pilot study, researchers at St. Jude Children's Research Hospital hope to explore whether teenagers and young adults with cancer want to participate in a writing exercise and whether they find it to be valuable. Primary Objective To assess the feasibility and acceptability of a writing-based narrative medicine intervention for adolescent and young adult patients with cancer.
Primary Outcome
To determine intervention feasibility, the number of touchpoints that participants have with the narrative medicine expert/guide will be tracked
Conditions Studied
Interventions
- BEHAVIORAL Interview
- BEHAVIORAL Writing
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2023-08-02 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT05975333 shows while recruiting
NCT05975333 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 241-participant average among 8 other Cancer Patients trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Cancer Patients appearing as the primary indexed condition, and to 2 interventions - of which Interview is the first listed.
NCT05975333 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT05975333 about?
NCT05975333 is a clinical study titled "Writing Intervention With Adolescents and Young Adults With Cancer". Young people with cancer have difficult experiences and writing exercises may help improve their well-being. However, very few studies have examined how a creative writing activity might be useful for young people with cancer. In this pilot study, researchers at St. Jude Children's Research Hospital...
What is the current status of trial NCT05975333?
This trial is currently recruiting. It is a NA study. The enrollment target is 26 participants. The study started on 2023-08-02. Estimated completion is 2026-12.
What conditions does trial NCT05975333 study?
This clinical trial studies the following conditions: Cancer Patients, Communication Research.
What interventions are being tested in trial NCT05975333?
The interventions under investigation include: Interview (BEHAVIORAL), Writing (BEHAVIORAL).
Who is sponsoring clinical trial NCT05975333?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05975333 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Patients
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05975333's enrollment target sits among peer trials
26 8th of 8 higher than 1 of 8 other Cancer Patients trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer Patients trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity
RECRUITING · NA
-
A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers
RECRUITING · NA
-
A Study Comparing Two Types of Supportive Interventions for Caregivers of Patients With Cancer
ACTIVE NOT RECRUITING · NA
-
Bright IDEAS - Young Adults Problem-Solving Skills Training
ACTIVE NOT RECRUITING · NA
-
A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their Pain
RECRUITING · Phase 1
-
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI